Glucagon-like peptide-1 ( GLP-1) receptor agonists could help manage hidradenitis suppurativa (HS) , with up to 60% of patients showing significant improvement after six months, according to a research letter recently published in JAMA Dermatology.

HS is a chronic inflammatory skin disease characterized by painful, draining nodules and abscesses that typically form in areas where skin rubs together, such as the underarms, groin and beneath the breasts . The condition is often misdiagnosed as acne or boils , but its long-term effects can be much more severe, leading to scarring, restricted mobility and reductions in quality of life.

While it can be thought of as uncommon, HS is relatively widespread, affecting an estimated 1% to 2% of people in the U.S. According to the HS Foundation

See Full Page